José Alberto Ayala Ortiz selected as one of the top ten CEOs of 2023

  • Post published:August 22, 2023

We are very glad to announce that José Alberto Ayala Ortiz has been selected as one of the top ten CEOs of 2023. Industry Tech Outlook has chosen José, a full article has been issued at the magazine website, it can be found here: https://industry-techoutlook.com/magazine/Top-10-CEOs-Of-2023/ Being the CEO of PVpharm, José is a visionary and inspirational leader. He sets a clear direction for the organization's future while motivating and uniting the organization. José’s leadership drives growth, innovation, and success, creating a positive work environment, attracting top talent, and building solid stakeholder relationships. The company has been growing in business since…

Continue ReadingJosé Alberto Ayala Ortiz selected as one of the top ten CEOs of 2023

PVpharm selected as one of the top ten companies providing compliance services and transforming business

  • Post published:December 9, 2020

We are very glad to announce that PVpharm has been selected as one of the top ten companies providing compliance services and transforming business. The European edition of PharmaTech Outlook www.pharmatechoutlook.com has choosen us, a full article has been issued at the magazine website, it can be found here: https://compliance-europe.pharmatechoutlook.com/vendor/pvpharm-solving-the-riddle-of-pharmacovigilance-compliance--cid-1039-mid-107.html This recognition is coming in a very important moment for PVpharm. Thanks to the effort and good work of the team, PVpharm is growing and helping more companies. Also, PVpharm is initiating new strategic partnerships in order to support other companies in their Pharmacovigilance activities. Please read more about us…

Continue ReadingPVpharm selected as one of the top ten companies providing compliance services and transforming business

ISO/ICH E2B(R3) Individual Case Safety Reporting in the EU: Hands-on Training Course using the EudraVigilance System Madrid (25th-27th March)

  • Post published:January 31, 2020

PVpharm is pleased to inform that our CEO, Jose Alberto Ayala Ortiz, will be participating as an instructor in a hands-on training course on the ISO/ICH E2B(R3) Individual Case Safety Reporting in the EU. The course will take place in Madrid from 25th to 27th of March and will provide the extensive information regarding EMA required knowledge evaluation, on how to report, view and download ICSRs using the EudraVigilance system and principles of EVDAS. This hands-on training course covers: In depth explanation and practical examples for creating, sending and accessing ICSRs in the ISO/ICH E2B(R3) format based on the EU ICSR…

Continue ReadingISO/ICH E2B(R3) Individual Case Safety Reporting in the EU: Hands-on Training Course using the EudraVigilance System Madrid (25th-27th March)

EVWEB and XEVMPD Training in Amsterdam (16th-20th September)

  • Post published:July 9, 2019

From the 16th to the 20th September, José Alberto Ayala Ortiz will be participating as an instructor on the EVWEB and XEVMPD training courses provided by the European Medicines Agency (EMA) in Amsterdam. From the 16th to the 18th September, a hands-on Training Course using the EudraVigilance System will be provided. This training course covers:-Explanation and practical examples for creating, sending and accessing ICSRs in the ISO/ICH E2B (R3).-The use of EudraVigilance web application (EVWEB) functionalities to describe the use of the E2B(R3).-Reporting principles in accordance with the guideline on good pharmacovigilance practices (GVP) Module VI "Management and reporting of…

Continue ReadingEVWEB and XEVMPD Training in Amsterdam (16th-20th September)

EVWEB and XEVMPD Basel (24th – 28th June)

  • Post published:July 9, 2019

From the 24th to the 26th June, the European Medicines Agency (EMA) provided an EVWEB training course in Basel, Switzerland. PVpharm's CEO, José Alberto Ayala Ortiz had the honor to participate as one of the instructors. The training focused mainly on explaining the guidance and specifically the mandatory data elements necessary for the electronic submission of information on medicinal products. Practical exercises were also included on the training for a better understanding and put in practice the acquired knowledge. In the same location, from the 2th to the 28th June, EMA also provided a XEVMPD (eXtended EudraVigilance Medicinal Product Dictionary)…

Continue ReadingEVWEB and XEVMPD Basel (24th – 28th June)